Downstream Processing Featured Articles

  1. FDA Approves New Seasonal Influenza Vaccine Made Using Novel Technology 1/16/2013

    The U.S. Food and Drug Administration recently announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

  2. Stratagene Introduces A New Product For Human Splice Variant Discovery 4/5/2006
    Stratagene Corporation, a developer, manufacturer and marketer of specialized life science research and diagnostic products, announced the commercial availability of the Human SpliceMiner cDNA Library Panel
  3. Waters UltraPerformance Convergence Chromatography Ushers In New Category Of Separation Science At Pittcon 3/13/2012
    Waters Corporation recently drew back the curtain on several important new technologies and a new business venture at Pittcon 2012, the industry’s most important annual new product conference and exhibition.
  4. NIST Study Suggests Carbon Nanotubes May Protect DNA From Oxidation 11/14/2012

    Researchers at the National Institute of Standards and Technology (NIST) have provided evidence in the laboratory that single-wall carbon nanotubes (SWCNTs) may help protect DNA molecules from damage by oxidation.

  5. iBio, Inc. And GE Healthcare Form New Global Alliance 7/26/2012

    iBio, Inc., and GE Healthcare, the healthcare business of GE, announced recently a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

  6. 3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products 5/4/2012

    3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules.  The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.

  7. Stainless Steel Vial Filling System Developed For Use In Vaccine Facilities 7/17/2014

    TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, recently announced the development of a stainless steel version of the fill-it system, designed for safely dispensing biohazardous materials such as vaccine stocks.

  8. Designer Bacteria May Lead To Better Vaccines 1/15/2013

    Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

  9. Advanced BioScience Laboratories Awards Avid Bioservices HIV Vaccine Development And Manufacturing Contract 9/27/2012

    Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc., today announced that it has been chosen by Advanced BioScience Laboratories, Inc. (ABL) to provide development and large-scale manufacturing services to support cGMP production of an HIV envelope protein, as a component of a preventive vaccine against HIV infection.

  10. The Medicines Company And Bristol-Myers Squibb Begin Global Alliance For Recothrom® 2/8/2013

    The Medicines Company (NASDAQ: MDCO) announced today that the global license and two-year collaboration for Recothrom®, a recombinant thrombin approved by the U.S.